| George | Ball | Center for the Business of Life Sciences | Operations and Supply Chain. | FDA regulatory policy, pharmaceutical quality, drug shortages, medical device quality and innovation FDA-related recalls, quality, shortages, executive decision-making biases Econometrics, secondary data, experimentation |
| Hilol | Bala | Center for the Business of Life Sciences | Information systems & technology | Impact of technologies on hospital performace, doctor/nurse productivity, and other healthcare outcomes Impact of technologies/digitalizations on organzational and invidual outcomes Econometrics, secondary data, experimentation, surveys, case studies (qualitative) |
| Kurt | Bretthauer | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare Nurse staffing Modeling, optimization |
| Christopher | Chen | Center for the Business of Life Sciences | Operations and Supply Chain | alternative payment models, provider organizational structure, healthcare Provider incentives on operations and patient outcomes, demand forecasting/management Econometrics, primary/secondary data, machine learning |
| Helen | Colby | Center for the Business of Life Sciences | Marketing | Healthcare, Pharmaceuticals vaccine incentives, health decision-making, self-control and goals, information effects empirical and statistical analysis |
| Jonathan | Helm | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare, Pharmaceuticals, Medical Devices Hospital Operations, AI for Personalized Medicine, Substance Use Disorder Prediction, Optimization, and Decision Support |
| Krista | Li | Center for the Business of Life Sciences | Marketing | Pharmaceuticals Product Design, Behavior-Based Targeting, New Product Development, Innovation Game Theory, Behavioral Economics, Empirical Modeling |
| Haizhen | Lin | Center for the Business of Life Sciences | Health economics and firm organization | health insurance, hospitals, medical devices physican behavior, hospital decisions, GPOs econometric analysis of data |
| Paola | Martin | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare, Pharmaceuticals organ transplant management, vaccine financing, vendor financing mathematical models |
| Jorge | Mejia | Center for the Business of Life Sciences | Information systems & technology | Healthcare, Pharmaceuticals Physician payment and healthcare costs, pharmaceutical supply chains econometric analysis of data, machine learning, statistics |
| Rob | Neal | Center for the Business of Life Sciences | Risk Management and ML | Predictive models for adverse events Healthcare clustering ,transitions, and dynamics Deep clustering, LSTM, sequence-to-sequence |
| RJ | Niewoehner | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare and Hospital Operations Clinician productivity, behavior, discretion Empiricial/econometric methods, including field experiments and archival data analysis |
| Rodney | Parker | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare Clinical decision making, transplant operations, payment policies Optimization, Game theory |
| Aaron | Perry | Center for the Business of Life Sciences | Operations and Supply Chain | Healthcare and hospital operations Improving healtchare delivery process through data analytics Optimization and data analytics |
| Phil | Powell | Center for the Business of Life Sciences | Health Economics | Business models for health services delivery Physician behavior, disruptive innovation in health care, public policy Econometrics, case studies |
| Lucy | Yan | Center for the Business of Life Sciences | health IT and H2.0 | health management, healthcare mhealth in promoting healthcare engagement econometric methods, machine learning, field experiments |
| Sha | Cao | School of Medicine | Biostatistics & Health Data Science | Dr. Cao specializes in omics, multiomics, scRNA-seq, and ST data analysis. She is also heavily focused on ML and DL bioinformatics methods development. Her primary disease area of interest is cancer |
| George | Eckert | School of Medicine | Biostatistics & Health Data Science | George Eckert specializes in Biostatistics, applied statistics to support IUSM. He is the director of the Biostatistics Services in BHDS. |
| David | Haggstrom | School of Medicine | Health services | Dr. Haggstrom specializes in cancer health services research, personal health records, and clinical decision making. His primary disease area of interest is cancer. He is the director of the Center for Health Services Research at Regenstrief Institute. |
| Kun | Huang | School of Medicine | Biostatistics & Health Data Science | Dr. Huang specializes in image analysis, real world evidence (RWE), multiomics, ML, and deep learning (DL). His disease areas of interest include: cancers and dementia. He is the chair of BHDS, associate director for Data Science at IUSCCC, and a Regenstrief Institute research scientist. |
| Sarath | Janga | School of Medicine | Biostatistics & Health Data Science | Dr. Janga specializes in novel methods development and applied bioinformatics. His primary areas of interest include: model organisms, liver, brain, kidney, and immune tissues. He is the chair of the Department of BioHealth Informatics. |
| Yunlong | Liu | School of Medicine | Medical & Molecular Genetics | Dr. Liu’s core specializes in sequencing analysis including but not limited to whole genome sequencing (WGS), whole exome sequencing (WES), single cell RNA sequencing (scRNA-seq), single cell multiomics, ATAC-seq, RNA-seq, and spatial transcriptomics (ST). His research is focused on machine learning (ML) and novel sequencing analysis techniques. His disease areas of interest include dementia, cancer, and addiction. He is the director of the sequencing core called the Center for Medical Genomics (CMG). |
| Patrick | Monahan | School of Medicine | Biostatistics & Health Data Science | Dr. Monahan specializes in statistical theory and clinical trial data analysis. His primary disease areas of interest are behavioral medicine and mental health. |
| Susan | Perkins | School of Medicine | Biostatistics & Health Data Science | Dr. Perkins specializes in categorical data analysis especially in biomedical studies involving qualitative outcomes. Her primary disease area of interest is cancer. She is the Director of the Design and Biostatistics Program of the Indiana Clinical and Translational Sciences Institute. |
| Jing | Su | School of Medicine | Biostatistics, Health Data Science, and Data Management | Dr. Su specializes in ML, DL, and graph-based ML with applications in scRNA-seq, ST, multiomics, and RWE. His primary disease areas of interest include: cancer, kidney, COVID, and dementia. He is the director of Data Management services through BHDS. |
| Jun | Wan | School of Medicine | Medical & Molecular Genetics | Dr. Wan specializes in novel bioinformatics methods development and applied bioinformatics. His primary disease area of interest is cancer. He is the director of the Collaborative Core for Cancer Bioinformatics (C3B). |
| Yong | Zang | School of Medicine | Biostatistics & Health Data Science | Dr. Zang specializes in time series data and advanced clinical trial design. His methods development focus is on Bayesian approaches to clinical trial and time series data analysis. |